Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE

Xiaojun He(Huazhong University of Science and Technology), Chuansheng Zheng(Union Hospital)
Oncotarget
December 11, 2017
Cited by 24


Related Papers